Tuesday, July 27, 2021

Special Reports

TIYGA: the voice of the Patient

WHO defines empowerment as “a process through which people gain greater control over decisions and actions affecting their health” (WHO 1998).  This shift is...

The relationship between chronic disease and COVID-19

Biomedical science, and with it the discovery of the causes of diseases, was changed with Antoine van Leeuwenhoek’s microscope 300 year ago – where...

Rethinking orthotics

Andiamo provides fast, affordable, comfortable and effective orthoses by reshaping biomechanical supports using 3D technology Faster production, enhanced comfort, lower costs and vastly improved patient...

Vindicating vibrometry

Researchers from the Medtronic Bakken Research Centre in Maastricht, the Netherlands, explain the use of vibrometry in CVD detection Cardiovascular disease (CVD) encompasses diseases of...

Tilray – Advancing Cannabinoid Science

Tilray’s Medical Advisory Board facilitates ground-breaking advancements in cannabinoid science. Tilray, a Canadian federally-licensed global leader in medical cannabis research and production, is proud to...

Adoption of innovation is essential to the future of osteoporosis care

The reality of healthcare in 2020 is that innovations that can have a positive impact on patient care aren’t always readily available to those...

Osteoporosis, fragility fractures and the urgent need for prioritisation of care

Osteoporosis is the world’s most common bone disease; affecting approximately 200 million people globally,1 it results in more than 8.9 million fragility fractures each...

Beyond the Fracture Liaison Service (FLS): addressing the management and treatment...

The past few years saw significant progress in the osteoporosis management landscape, but are all patients feeling the benefit? The introduction of the Fracture Liaison...

Everything you need to know about the annual MPS therapy week

From 11 July to 20 July 2019, the annual MPS therapy week and bi-annual MPS Conference was hosted in Hinterglemm, in the South-East of...

Meeting the challenges in unscheduled care delivery

Unscheduled Care (UC) services provide substantial health benefits, but increasing demand is leading to unsustainable pressure on these services – discover the CUREd dataset,...

Saving NHS funding: Better medication management could save the NHS over...

NHS funding is at the forefront of national concern. Discover how PillTime Ltd. facilitates medication management to alleviate mounting pressure on existing resources. Over 50%...

Science off the beaten track

Since 2004 the main interest of Jeanette Erdmann´s scientific work has been the identification of the genetic causes of coronary heart disease (CHD) and...

A mobile decision facilitator for oncology treatment

Christophe Vergne and Jean-Alexandre Kaminisky had known each other for a decade, working as competitors for many years, but they thought it was time...

Putting patients first by making cannabinoid medicinal products available

Tilray makes cannabinoid medicinal products available to patients in a time frame that matters and urges others to do the same Focusing on patients, their...

The function of immune cells in combating cancer

The incidence of cancer has dramatically increased over the last 50 years as a result of prolonged life expectancy and the Western lifestyle. Recent...

Narratives in support of training for personalised healthcare

In the past, our health systems were established primarily to save lives. Emphasis was on correct clinical procedure for efficient and effective intervention, there...

How is data integrity changing?

David Thompson of Clarity Compliance Solutions Ltd explains why data integrity is not just about data risk assessments. The issue of data integrity (DI) has...

The Matchmaker Exchange connects researchers and clinicians to identify novel Mendelian...

The Matchmaker Exchange (MME) was initiated in October 2013 as a community-organized effort to connect clinicians and researchers with rare cases. Matchmakers had evolved...

Key areas of research in the diagnosis and treatment of MPS...

Professor Dr François Eyskens of PCMA vzw discusses early diagnosis of MPS diseases by creating awareness and using a tandem mass spectrometry screening method. MPS...

Advancing cannabinoid therapies through research

Canada’s medical cannabis company Tilray defines a medical path for cannabinoid use Tilray is actively pursuing the daunting goal of delivering innovative, safe and effective...

Health News

Health eBooks

Health Partners

Pin It on Pinterest